Fiche du document
24 janvier 2025
- 10938/25256
- 37953311.0
- 2-s2.0-85176570519
Ce document est lié à :
Scientific Reports
Mots-clés
Hep g2 cells Humans Lipid metabolism Liver Lysophospholipids Non-alcoholic fatty liver disease Phosphatidylinositol 3-kinases Ppar gamma Sterol regulatory element binding protein 1 Tor serine-threonine kinases Fty 720p Lysophospholipid Peroxisome proliferator activated receptor gamma Phosphatidylinositol 3 kinase Sphingosine 1-phosphate Target of rapamycin kinase Hep-g2 cell line Human Metabolism Nonalcoholic fatty liverSujets proches
Lipid metabolism illnessCiter ce document
Rida et al., « Effect of FTY720P on lipid accumulation in HEPG2 cells », American University of Beirut ScholarWorks
Partage / Export
Résumé
Nonalcoholic fatty liver disease (NAFLD) is characterized by an increase in hepatic lipid accumulation due to impaired lipid metabolism. Although a correlation was found between NAFLD and sphingosine-1-phosphate (S1P), the role of the sphingolipid remains controversial. The aim of this study was to investigate any involvement of S1P in steatosis using its analog FTY720P and HepG2 cells. Lipid accumulation was induced by incubating the cells in a mixture of oleic and palmitic acid, and was quantified using Oil Red O. The involvement of signaling mediators was studied using pharmacological inhibitors and western blot analysis. FTY720P increased lipid accumulation, but this increase wasn’t maintained in the presence of inhibitors of S1PR3, Gq, SREBP, mTOR, PI3K, and PPARγ indicating their involvement in the process. The results revealed that FTY720P binds to S1PR3 which activates sequentially Gq, PI3K, and mTOR leading to an increase in SREBP expression and PPARγ activation. It was concluded that in presence of a high level of fatty acids, lipid accumulation is increased in hepatocytes by the exogenously added FTY720P. © 2023, The Author(s).
